AIM
BIO icon

Artemis Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Artemis Investment Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-194,607
Closed -$81.3M – 227
2022
Q3 		$81.3M Sell
194,607
-1,180
-0.6% -$588K 0.93% 36
2022
Q2 		$97M Buy
195,787
+96,691
+98% +$50.4M 1% 31
2022
Q1 		$55.7M Sell
99,096
-40,881
-29% -$24.6M 0.45% 68
2021
Q4 		$106M Buy
139,977
+13,275
+10% +$9.93M 0.77% 36
2021
Q3 		$94.4M Buy
126,702
+13,827
+12% +$10.4M 0.75% 35
2021
Q2 		$72.8M Buy
112,875
+29,135
+35% +$17.7M 0.63% 47
2021
Q1 		$47.8M Sell
83,740
-25,131
-23% -$14.9M 0.45% 63
2020
Q4 		$63.6M Sell
108,871
-24,357
-18% -$13.9M 0.66% 46
2020
Q3 		$68.6M Sell
133,228
-65,030
-33% -$32.9M 0.86% 30
2020
Q2 		$89.7M Sell
198,258
-60,383
-23% -$26.6M 1.21% 20
2020
Q1 		$89.9M Buy
258,641
+146,088
+130% +$53.7M 0.15% 14
2019
Q4 		$40.7M Buy
112,553
+20,151
+22% +$7.1M 0.51% 61
2019
Q3 		$30M Buy
92,402
+35,638
+63% +$11.6M 0.41% 83
2019
Q2 		$17.2M Buy
56,764
+16,936
+43% +$5.07M 0.2% 144
2019
Q1 		$12.2M Buy
39,828
+20,477
+106% +$5.53M 0.14% 179
2018
Q4 		$4.49M Sell
19,351
-380
-2% -$102K 0.06% 219
2018
Q3 		$6.18M Buy
+19,731
New +$6.12M 0.07% 236

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Artemis Investment Management's BIO Position: Q4 2022 in Review

Artemis Investment Management sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2022, closing a stake of 194,607 shares — an estimated $81.3M sold.

Artemis Investment Management first reported a position in BIO in Q3 2018 and held it in 17 quarters. The position peaked at $106M in Q4 2021. 470 funds tracked by Wall St. Rank hold BIO as of Q4 2022.

  • Artemis Investment Management reported no remaining Bio-Rad Laboratories Class A position as of Q4 2022 after selling out during the quarter.
  • Artemis Investment Management sold 194,607 Bio-Rad Laboratories Class A shares in Q4 2022, an estimated $81.3M.
  • Artemis Investment Management first reported a position in Bio-Rad Laboratories Class A in Q3 2018 and held it in 17 quarters.
  • Artemis Investment Management's Bio-Rad Laboratories Class A position peaked at $106M in Q4 2021.
  • 470 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2022.

Based on Artemis Investment Management's 13F filing for Q4 2022, filed 25 Jan 2023.